42
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Potential Mechanisms of Improvement of Airway Hyperresponsiveness by Inhaled Corticosteroid Therapy in Asthmatic Patients

, M.D., , M.D., , M.D., , M.D., , M.D. & , M.D.
Pages 113-117 | Published online: 02 Jul 2009

REFERENCES

  • Gleich G J. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990; 85: 422–436, [PUBMED], [INFOTRIEVE], [CSA]
  • Bousquet J, Chanez P, Lacoste J Y, Barneon G, Ghavanian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel F B. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033–1039, [PUBMED], [INFOTRIEVE], [CSA]
  • Ohashi Y, Motojima S, Fukuda T, Makino S. Airway hyperresponsiveness, increased intracellular spaces of bronchial epithelium, and increased infiltration of eosinophils and lymphocytes in bronchial mucosa in asthma. Am Rev Respir Dis 1992; 145: 1469–1476, [PUBMED], [INFOTRIEVE], [CSA]
  • Ying S, Humbert M, Barkans J, Corrigan C J, Pfister R, Menz G, Larche M, Robinson D S, Durham S R, Kay A B. Expression of IL-4 and IL-5 mRNA and protein product by CD4+ and CD8+ T cells, eosinophils, and mast cells in bronchial biopsies obtained from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1997; 158: 3539–3544, [PUBMED], [INFOTRIEVE], [CSA]
  • Hamid Q, Azzawi M, Ying S, Moqbel R, Wardlaw A J, Corrigan C J, Bradley B, Durham S R, Collins J V, Jeffery P K, Quint D J, Kay A B. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J Clin Invest 1991; 87: 1541–1546, [PUBMED], [INFOTRIEVE], [CSA]
  • Robinson D S, Ying S, Bentley A M, Meng Q, North J, Durham S R, Kay A B, Hamid Q. Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma. J Allergy Clin Immunol 1993; 92: 397–403, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Shi H Z, Xiao C Q, Zhong D, Qin S M, Liu Y, Liang G R, Xu H, Chen Y Q, Long X M, Xie Z F. Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. AM J Respir Crit Care Med 1998; 157: 204–209, [PUBMED], [INFOTRIEVE], [CSA]
  • Kips J C, O'Connor B J, Langley S J, Woodcock A, Kerstjens H A, Postma D S, Danzig M, Cuss F, Pauwels R A. Effect of SCH55700, a humanized anti–human interleukin-5 antibody, in severe persistent asthma: a pilot study. AM J Respir Crit Care Med 2003; 167: 1655–1659, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Leckie M J, ten Brinke A, Khan J, Diamant Z, O'Connor B J, Walls C M, Mathur A K, Cowley H C, Chung K F, Djukanovic R, Hansel T T, Holgate S T, Sterk P J, Barnes P J. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000; 356: 2144–2148, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Eum S Y, Maghni K, Hamid Q, Eidelman D H, Campbell H, Isogai S, Martin J G. Inhibition of allergic airways inflammation and airway hyperresponsiveness in mice by dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J Allergy Clin Immunol 2003; 111: 1049–1061, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Kimura K, Inoue H, Ichinose M, Miura M, Katsumata U, Takahashi T, Takishima T. Bradykinin causes airway hyperresponsiveness and enhances maximal airway narrowing. Role of microvascular leakage and airway edema. Am Rev Respir Dis 1992; 146: 1301–1305, [PUBMED], [INFOTRIEVE], [CSA]
  • Vande Graaf E A, Out T A, Roos C M, Jansen H M. Respiratory membrane permeability and bronchial hyperreactivity in patients with stable asthma. Effects of therapy with inhaled steroids. Am Rev Respir Dis 1991; 143: 362–368, [CSA]
  • Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987; 136: 225–244, [CSA]
  • Yoshikawa T, Shoji S, Fujii T, Kanazawa H, Kudoh S, Hirata K, Yoshikawa J. Severity of exercise-induced bronchoconstriction is related to airway eosinophilic inflammation in patients with asthma. Eur Respir J 1998; 12: 879–884, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Kanazawa H, Asai K, Hirata K, Yoshikawa J. Vascular involvement in exercise-induced airway narrowing in patients with bronchial asthma. Chest 2002; 122: 166–170, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Van Rensen E L, Hiemstra P S, Rabe K F, Sterk P J. Assessment of microvascular leakage via sputum induction: the role of substance P and neurokinin A in patients with asthma. AM J Respir Crit Care Med 2002; 165: 1275–1279, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Alvarez-Puebla M J, Olaguibel-Rivera J M, Urbiola-Marcilla E, Garcia B E, Tabar-Purroy A I. Determinants of allergen-induced late bronchial responses in mild asthmatics. Chest 2001; 119: 120–127, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Pizzichini M M, Pizzichini E, Efthimiadis A, Chauhan A J, Johnston S L, Hussack P, Mahony J, Dolovich J, Hargreave F E. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study. AM J Respir Crit Care Med 1998; 158: 1178–1184, [PUBMED], [INFOTRIEVE], [CSA]
  • Kelly M M, Leigh R, Carruthers S, Horsewood P, Gleich G J, Hargreave F E, Cox G. Increased detection of interleukin-5 in sputum by addition of protease inhibitors. Eur Respir J 2001; 18: 685–691, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Park S W, Kim do J, Chang H S, Park S J, Lee Y M, Park J S, Chung I Y, Lee J H, Park C S. Association of interleukin-5 and eotaxin with acute exacerbation of asthma. Int Arch Allergy Immunol 2003; 131: 283–290, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • van Rensen E L, Stirling R G, Scheerens J, Staples K, Sterk P J, Barnes P J, Chung K F. Evidence for systemic rather than pulmonary effects of interleukin-5 administration in asthma. Thorax 2001; 56: 935–940, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Jatakanon A, Uasuf C, Maziak W, Chung K F, Barnes P J. Neutrophilic inflammation in severe persistent asthma. AM J Respir Crit Care Med 1999; 160: 1532–1539, [PUBMED], [INFOTRIEVE], [CSA]
  • Bentley A M, Hamid Q, Robinson D S, Schotman E, Meng Q, Assoufi B, Kay A B, Durham S R. Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. AM J Respir Crit Care Med 1996; 153: 551–556, [PUBMED], [INFOTRIEVE], [CSA]
  • Lee J J, McGarry M P, Farmer S C, Denzler K L, Larson K A, Carrigan P E, Brenneise I E, Horton M A, Haczku A, Gelfand E W, Leikauf G D, Lee N A. Interleukin-5 expression in the lung epithelium of transgenic mice leads to pulmonary changes pathognomonic of asthma. J Exp Med 1997; 185: 2143–2156, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Foster P S, Hogan S P, Ramsay A J, Matthaei K I, Young I G. Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 1996; 183: 195–201, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Eum S Y, Haile S, Lefort J, Huerre M, Vargaftig B B. Eosinophil recruitment into the respiratory epithelium following antigenic challenge in hyper-IgE mice is accompanied by interleukin 5-dependent bronchial hyperresponsiveness. Proc Natl Acad Sci USA 1995; 92: 12290–12294, [PUBMED], [INFOTRIEVE], [CSA]
  • Corry D B, Folkesson H G, Warnock M L, Erle D J, Matthay M A, Wiener-Kronish J P, Locksley R M. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J Exp Med 1996; 183: 109–117, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Schleimer R P. An overview of glucocorticoid anti-inflammatory actions. Eur J Clin Pharmacol 1993; 45(suppl 1)S3–7, discussion S43-44[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Goldie R G, Pedersen K E. Mechanisms of increased airway microvascular permeability: role in airway inflammation and obstruction. Clin Exp Pharmacol Physiol 1995; 22: 387–396, [PUBMED], [INFOTRIEVE], [CSA]
  • Kanazawa H, Nomura S, Yoshikawa J. Role of microvascular permeability on physiologic differences in asthma and eosinophilic bronchitis. AM J Respir Crit Care Med 2004; 169: 1125–1130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Foster P S, Mould A W, Yang M, Mackenzie J, Mattes J, Hogan S P, Mahalingam S, McKenzie A N, Rothenberg M E, Young I G, Matthaei K I, Webb D C. Elemental signals regulating eosinophil accumulation in the lung. Immunol Rev 2001; 179: 173–181, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Chetta A, Zanini A, Foresi A, Del Donno M, Castagnaro A, D'Ippolito R, Baraldo S, Testi R, Saetta M, Olivieri D. Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. AM J Respir Crit Care Med 2003; 167: 751–757, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Jeffery P K, Godfrey R W, Adelroth E, Nelson F, Rogers A, Johansson S A. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992; 145: 890–899, [PUBMED], [INFOTRIEVE], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.